Hologic to Showcase Developments in Next-Generation AI Solutions at RSNA 2023
Summary
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) will showcase several recent developments in next-generation AI solutions at the 109th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 26 to 30. On the show floor and during multiple workshops, the global leader in breast imaging will unveil advances that leverage AI to improve cancer detection, workflow and patient satisfaction. Hologic is currently exploring new product features to drive toward even greater accuracy and efficient breast care, including: In the South Hall, Level 3, Booth 1919 at McCormick Place, guests can experience Hologic’s comprehensive portfolio, including the Dimensions® mammography portfolio, Affirm® Contrast Biopsy software, I-View® Contrast Enhanced Mammography software and a full suite of breast biopsy and surgery solutions. Additionally, the Company will host a CME-accredited symposium and lunch-and-learn sessions, including: • Advancements in Breast Imaging with Contrast-Enhanced Mammography Sunday, Nov. 26: 11:45 a.m. – 12:45 p.m. CST (South Building, Level 5, Room S502) Join Dr. Chiara Bellini and Dr. Michael Morris as they explore the latest in Contrast-Enhanced Mammography and its impact on breast imaging in Europe and the U.S. Hologic, Inc. is a global medical technology innovator focused on improving the health and well-being of women, their families and communities through early detection and treatment.